Induction of cytochrome P450 enzymes by albendazole treatment in the rat

Environmental Toxicology and Pharmacology

Volumn 9, Issue 1-2, 2000, Pages 31-37

  Asteinza, Josune ^a   Camacho Carranza, Rafael ^a   Reyes Reyes, R Eugenia ^b   Dorado González, Víctor ^b   Espinosa Aguirre, J Javier ^a,b  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

Author keywords

Albendazole; Anthelmintic; Cytochrome P450; Neurocysticercosis

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFONE; ALBENDAZOLE SULFOXIDE; ANTHELMINTIC AGENT; CARCINOGEN; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 ISOENZYME; ETHOXYRESORUFIN DEETHYLASE; MUTAGENIC AGENT; OXYGENASE; RESORUFIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN EXPRESSION; RAT;

ZEA MAYS;

EID: 0034533490     PISSN: 13826689     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1382-6689(00)00059-4     Document Type: Article

References (36)

1. Novel piperidine derivatives: Inhibitory properties towards cytochrome P450 isoforms, and cytoprotective and cytotoxic characteristics
2. The toxicity and dose of desipramine hydrochloride
3. Smoking and peripheral type of cancer are related to high levels of pulmonary cytochrome P450IA in lung cancer patients
4. Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer
5. A rapid and sensitive method for the cuantitation of microgram quantities of protein utilizing the principle of protein-dye binding
6. Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues: A series of substrates to distinguish between different induced cytochromes P-450
7. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver
8. Acetaminophen hepatotoxicity: Potentiation by isoniazid
9. A correlation of toxicity of albendazole and of oxfendazole with their free metabolites and bound residues
10. Toxicity of the antiandrogen flutamide in isolated rat hepatocytes
11. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins
12. Dexamethasone increases plasma levels of albendazole
13. Clinical pharmacokinetics of albendazole in patients with brain cysticercosis
14. Hydroxylation of p-nitrophenol by rabbit ethanol-inducible cytochrome P-450 isozyme 3a
15. Maturation of the head of bacteriophage T4 I DNA packaging events
16. P450 Substrate specificity and metabolism
17. Revised methods for the Salmonella mutagenicity test
18. N-Benzylimidazole, a potent inducer of rat liver enzymes involved in mutagenic activation of various carcinogens
19. Chiral sulfoxidation of albendazole by the flavin adenine dinucleotide-containing and cytochrome P450-dependent monooxygenases from rat liver microsomes
20. Cellular response to oxidative stress: The [Ah] gene battery as a paradigm
21. Aryl hydrocarbon hydroxylase activity in human breast cancer tissue
22. Acetaminophen activation by human liver cytochrome P450 IIE1 and P450 IA2
23. Enhancement of hepatocarcinogenesis and induction of cytochrome P450-dependent monooxygenase activities by the barbiturates allobarbital, aprobarbital, pentobarbital, secobarbital and 5-phenyl- and 5-ethylbarbituric acids
24. Evidence that isoniazid and ethanol induce the same microsomal cytochrome P-450 isozyme 3a
25. Albendazole as a potential treatment of human hydatidosis
26. DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis
27. Metabolism of the antiandrogenic drug (Flutamide) by human CYP1A2
28. Treatment of brain cysticercosis
29. Inducing effects of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics
30. Albendazole sulfonation by rat liver cytochrome P-450c
31. Anthelmintic activity of albendazole against liver flukes, tapeworms, lung and gastrointestinal round worms
32. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications
33. The cytotoxicity of clozapine metabolites: Implications for predicting clozapine-induced agranulocytosis
34. Characterization of the human hepatic cytochromes P450 involved in the in vitro oxidation of clozapine
35. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal, diazepam, 7-ethoxycoumarin, and imipramine metabolism